Loading viewer...
earnings
Format: PDF earnings
Ambu reports Q2 and H1 2024/25 results with 15.4% organic revenue growth and 15.2% EBIT margin expansion. The company achieved a strong start for its Ambu® SureLight™ Connect launch in pulmonology and continued positive momentum in urology. Management confirms current FY 2024/25 financial guidance.
investor_presentation
13 Pages
earnings
35 Pages
Align Technology
Wabash National Q1 2024 Earnings Release
earningsearnings
16 Pages
Wabash National Corporation
Antero Midstream Partners Q3 2016 Earnings Presentation
earningsearnings
11 Pages
Antero Midstream Partners LP